Kristen Buck
Equibles does not estimate personal net worth.
About Kristen Buck
The proxy statement of Lisata Therapeutics, Inc. reports total compensation of $1,065,061 for Kristen Buck in fiscal 2024, including a base salary of $597,421. Disclosed compensation is on record for 4 fiscal years. Kristen Buck has spoken on 2 earnings calls across 1 company, most recently for Lisata Therapeutics, Inc. on November 6, 2025. The companies whose calls Kristen Buck spoke on are classified in the Healthcare sector.
Kristen Buck on recent calls
“It's a pleasure to be here today to present an update on our clinical development portfolio, including near-term catalysts.”
“It's a pleasure to be here today to present an update on our clinical development portfolio, including near-term catalysts.”
Affiliation history
-
Lisata Therapeutics, Inc. (LSTA)
Proxy statement
Start not stated–2026-08-03
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $597,421 | $1,065,061 |
| 2023 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $574,443 | $969,817 |
| 2022 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $553,781 | $1,124,102 |
| 2021 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $183,333 | $1,858,333 |